In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells

article OA: closed CC0 ⤵ 27 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

This study investigated the effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells in vitro.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo investigate the in vitro effects of atorvastatin on lipopolysaccharide (LPS)-induced gene expression in endometrial-endometriotic stromal cells.DesignIn vitro experimental study using flow cytometry, ELISA, semiquantitative reverse transcriptase polymerase chain reaction, and Western blot.SettingPostgraduate Institute of Medical Education and Research.Patient(s)Twenty-five women undergoing laparoscopy (n = 10) and laparotomy (n = 15).Intervention(s)Endometriotic cyst wall (group I) and endometrial biopsy (group II) collection.Main outcome measure(s)The endometrial-endometriotic stromal cells were isolated from ectopic (group I) and eutopic (group II) endometrium by established methods, cultured, and stimulated with LPS (1 μg/mL), followed by atorvastatin treatment in a time- and dose-dependent manner to investigate the effects of LPS on proliferation (Ki-67) and expression of cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF), receptor for advanced glycation end products (RAGE), extracellular newly identified RAGE binding protein (EN-RAGE), peroxisome proliferator activated receptor-γ (PPAR-γ), and liver X receptor-α (LXR-α) genes in endometrial-endometriotic stromal cells and on levels of insulin-like growth factor binding protein-1 (IGFBP-1) and 17β-E(2) in endometrial-endometriotic stromal cell culture supernatant.Result(s)Significant inhibition of Ki-67 and LPS-induced expression of inflammatory and angiogenic genes (COX-2, VEGF, RAGE, and EN-RAGE) was observed in atorvastatin-treated endometrial-endometriotic stromal cells. In contrast, a significant dose- and time-dependent increase in expression of anti-inflammatory genes (PPAR-γ and LXR-α) and levels of IGFBP-1 was observed after atorvastatin treatment in both the groups. However, atorvastatin treatment had no effect on 17β-E(2) levels in endometrial/endometriotic stromal cell culture supernatant.Conclusion(s)The data of the present study provide new insights for the implication of atorvastatin treatment for endometriosis in humans.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Gene Expression Regulation Heptanoic Acids Lipopolysaccharides Pyrroles Uterine Diseases Adolescent Adult Atorvastatin Biopsy Case-Control Studies Cell Differentiation Cell Differentiation Cell Proliferation Cell Proliferation Cells, Cultured Cell Survival Cell Survival Cyclooxygenase 2 Cyclooxygenase 2

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (55)

Cited by (27)

Source provenance

europepmc
last seen: 2026-08-29T06:12:09.280863+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:13:53.633898+00:00
License: CC0 · commercial use OK